1. LBA58Intracranial efficacy of brigatinib (BRG) vs crizotinib (CRZ) in the phase III ALTA-1L trial. (23rd October 2018) Authors: Popat, S; Kim, H R; Ahn, M-J; Yang, J C-H; Han, J-Y; Hochmair, M J; Lee, K H; Delmonte, A; Garcia Campelo, M R; Kim, D-W; Griesinger, F; Felip, E; Califano, R; Spira, A I; Gettinger, S; Tiseo, M; Haney, J; Kerstein, D; Camidge, D R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗